Skip to content

BNTC - Benitec Biopharma Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchB

Benitec Biopharma Ltd ADR

BNTC · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

B

BNTCBenitec Biopharma Ltd ADR

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $16.76
52-wk low: $9.85
Prev close: $14.89
Mkt cap: $442.5M
Beta: 0.26
P/S: 2770.1x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$50.2M

MI
Millennium
Israel Englander · Q2 2026 13F
$12.3M
position
BA
Balyasny
Dmitry Balyasny · Q2 2026 13F

Earnings

Earnings

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $442M

Valuation

P/S2770.13
P/B2.46

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: BNTC
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $442.48M
Beta: 0.26

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

2.5x

Profit margin

+0.0%

Op margin

+0.0%

ROE

-29.6%

$8.7M

position

SC

Schonfeld

Steven Schonfeld · Q2 2026 13F

$3.1M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for BNTC

No recent insider trade
No recent Congress trade
No recent market-voice mention

No earnings history on record for this stock yet.

The next reported quarter will appear here

Next report

Reports Sep 28, 2026, in 38 days

EPS expected

-$0.28

-$0.31 to -$0.25

Revenue expected

$0.00

4 analysts

Last 30 days

3up0down

Analysts raising estimates

-29.6%

ROA-19.9%

Growth

Beta0.26